A detailed history of New York State Common Retirement Fund transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 9,076 shares of VRCA stock, worth $72,154. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,076
Previous 9,076 -0.0%
Holding current value
$72,154
Previous $66,000 80.3%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$5.89 - $9.56 $4,081 - $6,625
-693 Reduced 7.09%
9,076 $66,000
Q1 2024

May 07, 2024

BUY
$4.74 - $6.81 $3,256 - $4,678
687 Added 7.56%
9,769 $58,000
Q4 2023

Feb 01, 2024

SELL
$2.93 - $7.32 $120 - $300
-41 Reduced 0.45%
9,082 $66,000
Q3 2023

Nov 07, 2023

SELL
$3.75 - $7.46 $27,288 - $54,286
-7,277 Reduced 44.37%
9,123 $35,000
Q2 2023

Aug 07, 2023

BUY
$5.32 - $6.79 $87,248 - $111,356
16,400 New
16,400 $95,000
Q2 2022

Aug 04, 2022

SELL
$1.81 - $8.93 $14,673 - $72,395
-8,107 Reduced 98.45%
128 $0
Q3 2021

Nov 02, 2021

BUY
$9.55 - $13.96 $162 - $237
17 Added 0.21%
8,235 $103,000
Q2 2021

Aug 02, 2021

BUY
$9.77 - $15.33 $1,084 - $1,701
111 Added 1.37%
8,218 $93,000
Q1 2021

May 11, 2021

BUY
$10.51 - $17.46 $35,807 - $59,486
3,407 Added 72.49%
8,107 $123,000
Q3 2020

Nov 05, 2020

SELL
$6.16 - $10.3 $56,056 - $93,730
-9,100 Reduced 65.94%
4,700 $36,000
Q2 2019

Aug 09, 2019

BUY
$7.1 - $11.62 $73,840 - $120,847
10,400 Added 305.88%
13,800 $160,000
Q4 2018

Feb 08, 2019

BUY
$6.75 - $16.12 $22,950 - $54,808
3,400 New
3,400 $28,000

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.